Uncategorized

Multivitamins May Slow Biological Aging

A recent study suggests that daily multivitamin-mineral supplements could slightly slow the biological aging process in older adults, though the effect size is modest and requires further investigation. As part of the COSMOS trial, researchers analyzed data from 958 participants over two years using advanced “epigenetic clocks”—DNA methylation measures that estimate biological age. The results showed a clear divergence between the two supplements tested. Compared with placebo, those taking a daily multivitamin (Centrum Silver) showed a modest but statistically significant reduction in aging rate on two second-generation clocks: PCGrimAge slowed by 0.113 years per year and PCPhenoAge slowed by 0.214 years per year . A critical interaction effect emerged based on baseline aging speed: the benefit on PCGrimAge was substantially stronger among participants already experiencing accelerated biological aging, with a slowing of 0.236 years per year , compared to -0.013 years in those with normal or decelerated aging. In contrast, cocoa extract supplements containing 500 mg of flavanols showed no statistically significant effect on any of the five epigenetic clocks tested, including the newer DunedinPACE measure. While the findings for multivitamins are promising, these small epigenetic changes need further study to determine whether they translate into meaningful reductions in age-related chronic conditions. Source: https://www.nature.com

hyangiu

Recent Posts

Lifestyle Intervention May Slow Early Cerebral Small-Vessel Injury

A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…

5 hours ago

Shared and Region-Specific Dementia Risk Factors

Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…

12 hours ago

Comparative Benefits and Risks of Anti-Obesity Drugs

A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…

3 days ago

Early Mild Hypertrophic Cardiomyopathy May Still Carry Significant Cardiovascular Risk

Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…

5 days ago

High-Intensity Interval Exercise Reduces Energy Intake in Adults With Overweight or Obesity

A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…

6 days ago

Proton Pump Inhibitor and Antibiotic Use May Reduce the Benefit of Immunotherapy in NSCLC

Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…

1 week ago

This website uses cookies.